Skip to main content

previous disabled Page of 13
and
  1. No Access

    Article

    Stable inhibition of choroidal neovascularization by adeno-associated virus 2/8-vectored bispecific molecules

    Neovascular age-related macular degeneration (nAMD) causes severe visual impairment. Pigment epithelium-derived factor (PEDF), soluble CD59 (sCD59), and soluble fms-like tyrosine kinase-1 (sFLT-1) are potentia...

    Tinghui Bai, Bohao Cui, Man **ng, Siyue Chen, Yanfang Zhu, Dongxue Lin in Gene Therapy (2024)

  2. Article

    Open Access

    Retinoic acid related orphan receptor α is a genetic modifier that rescues retinal degeneration in a mouse model of Stargardt disease and Dry AMD

    Degeneration of the macula is associated with several overlap** diseases including age-related macular degeneration (AMD) and Stargardt Disease (STGD). Mutations in ATP Binding Cassette Subfamily A Member 4 (AB...

    M. Akula, S. M. McNamee, Z. Love, N. Nasraty, N. P. M. Chan, M. Whalen in Gene Therapy (2024)

  3. Article

    Open Access

    Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates

    In this study, we demonstrate the safety and utility of CRISPR-Cas9 gene editing technology for in vivo editing of proviral DNA in ART-treated, virally controlled simian immunodeficiency virus (SIV) infected r...

    Tricia H. Burdo, Chen Chen, Rafal Kaminski, Ilker K. Sariyer in Gene Therapy (2024)

  4. No Access

    Article

    CSTB gene replacement improves neuroinflammation, neurodegeneration and ataxia in murine type 1 progressive myoclonus epilepsy

    EPM1 is the most common form of Progressive Myoclonus Epilepsy characterized by late-childhood onset, ever-worsening and disabling myoclonus, seizures, ataxia, psychiatric disease, and shortened lifespan. EPM1...

    Emrah Gumusgoz, Sahba Kasiri, Mayank Verma, Jun Wu, Daniel Villarreal Acha in Gene Therapy (2024)

  5. Article

    Open Access

    A multinational survey of potential participant perspectives on ocular gene therapy

    Amidst rapid advancements in ocular gene therapy, understanding patient perspectives is crucial for sha** future treatment choices and research directions. This international cross-sectional survey evaluated...

    Alexis Ceecee Britten-Jones, Myra B. McGuinness, Fred K. Chen in Gene Therapy (2024)

  6. Article

    Retraction Note: Long noncoding RNA RBMS3-AS3 acts as a microRNA-4534 sponge to inhibit the progression of prostate cancer by upregulating VASH1

    Zhenming Jiang, Yuxi Zhang, ** Chen, **eng Wu, Dong Chen in Gene Therapy (2024)

  7. Article

    Open Access

    Correction: Preclinical safety and biodistribution of CRISPR targeting SIV in non-human primates

    Tricia H. Burdo, Chen Chen, Rafal Kaminski, Ilker K. Sariyer in Gene Therapy (2024)

  8. Article

    Open Access

    Estimating genome-wide DNA methylation heterogeneity with methylation patterns

    In a heterogeneous population of cells, individual cells can behave differently and respond variably to the environment. This cellular diversity can be assessed by measuring DNA methylation patterns. The loci ...

    Pei-Yu Lin, Ya-Ting Chang, Yu-Chun Huang, Pao-Yang Chen in Epigenetics & Chromatin (2023)

  9. Article

    Open Access

    Successes and challenges in clinical gene therapy

    Despite the ups and downs in the field over three decades, the science of gene therapy has continued to advance and provide enduring treatments for increasing number of diseases. There are active clinical tria...

    Donald B. Kohn, Yvonne Y. Chen, Melissa J. Spencer in Gene Therapy (2023)

  10. Article

    Open Access

    Altered cfDNA fragmentation profile in hypomethylated regions as diagnostic markers in breast cancer

    Breast cancer, the most common malignancy in women worldwide, has been proven to have both altered plasma cell-free DNA (cfDNA) methylation and fragmentation profiles. Nevertheless, simultaneously detecting bo...

    Jun Wang, Yanqin Niu, Ming Yang, Lirong Shu, Hongxian Wang in Epigenetics & Chromatin (2023)

  11. Article

    Open Access

    Co-effects of m6A and chromatin accessibility dynamics in the regulation of cardiomyocyte differentiation

    Cardiomyocyte growth and differentiation rely on precise gene expression regulation, with epigenetic modifications emerging as key players in this intricate process. Among these modifications, N6-methyladenosi...

    Xue-Hong Liu, Zhun Liu, Ze-Hui Ren, Hong-Xuan Chen, Ying Zhang in Epigenetics & Chromatin (2023)

  12. No Access

    Article

    Suppression of bone metastatic castration-resistant prostate cancer cell growth by a suicide gene delivered by JC polyomavirus-like particles

    Prostate cancer is one of the most common cancers in men. The heterogeneity and mutations exhibited by prostate cancer cells often results in the progression to incurable metastatic castration-resistant prosta...

    Cheng-Huang Shen, Mien-Chun Lin, Chiung-Yao Fang, Pei-Lain Chen in Gene Therapy (2023)

  13. No Access

    Article

    Distinct functions of CAR-T cells possessing a dectin-1 intracellular signaling domain

    Chimeric antigen receptor T (CAR-T) cell therapy has demonstrated remarkable efficacies in treating hematopoietic malignancies, but not in the solid tumors. Incorporating costimulatory signaling domains, such ...

    **ao Liang, Yong Huang, Dan Li, **ao Yang, Lin Jiang, Weilin Zhou in Gene Therapy (2023)

  14. No Access

    Article

    Immune profiling of adeno-associated virus response identifies B cell-specific targets that enable vector re-administration in mice

    Adeno-associated virus (AAV) vector-based gene therapies can be applied to a wide range of diseases. AAV expression can last for months to years, but vector re-administration may be necessary to achieve life-l...

    Maria Chen, Boram Kim, Maria I. Jarvis, Samantha Fleury, Shuyun Deng in Gene Therapy (2023)

  15. Article

    In vivo genome editing using novel AAV-PHP variants rescues motor function deficits and extends survival in a SOD1-ALS mouse model

    CRISPR-based gene editing technology represents a promising approach to deliver therapies for inherited disorders, including amyotrophic lateral sclerosis (ALS). Toxic gain-of-function superoxide dismutase 1 (...

    Yi A. Chen, Mark W. Kankel, Sam Hana, Shukkwan Kelly Lau in Gene Therapy (2023)

  16. Article

    Open Access

    Survey of perspectives of people with inherited retinal diseases on ocular gene therapy in Australia

    Many gene therapies are in development for treating people with inherited retinal diseases (IRD). We hypothesized that potential recipients of gene therapy would have knowledge gaps regarding treatment. We aim...

    Heather G. Mack, Alexis Ceecee Britten-Jones, Myra B. McGuinness in Gene Therapy (2023)

  17. Article

    Open Access

    ATAC-seq and RNA-seq analysis unravel the mechanism of sex differentiation and infertility in sex reversal chicken

    Sex determination and differentiation are complex and delicate processes. In female chickens, the process of sex differentiation is sensitive and prone to be affected by the administration of aromatase inhibit...

    **uan Zhang, Jianbo Li, **qiong Wang, Yuchen Jie, Congjiao Sun in Epigenetics & Chromatin (2023)

  18. No Access

    Article

    Two high-fidelity variants: efSaCas9 and SaCas9-HF, which one is better?

    CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated endonuclease Cas9) nucleases have been widely applied for genome engineering. Staphylococcus aureus Cas9 (SaCas9) is com...

    **eng Lv, Haitao **, **ujuan Lv, Yue Zhou, Jiahua Wang, Haoran Chen in Gene Therapy (2022)

  19. Article

    Open Access

    Structural and functional specificity of H3K36 methylation

    The methylation of histone H3 at lysine 36 (H3K36me) is essential for maintaining genomic stability. Indeed, this methylation mark is essential for proper transcription, recombination, and DNA damage response....

    Ulysses Tsz Fung Lam, Bryan Kok Yan Tan, John Jia **n Poh in Epigenetics & Chromatin (2022)

  20. No Access

    Article

    Genome editing using CRISPR/Cas9 to treat hereditary hematological disorders

    The clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9 (CRISPR/Cas9) system is a versatile and convenient genome-editing tool with prospects in gene therapy. This technique i...

    Yan Chen, Ruiting Wen, Zhigang Yang, Zhanghui Chen in Gene Therapy (2022)

previous disabled Page of 13